These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25211094)

  • 1. Utility decrements associated with side effects in schizophrenia.
    Millier A; Amri I; Boyer L; Auquier P; Toumi M
    J Med Econ; 2014 Dec; 17(12):853-61. PubMed ID: 25211094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive models to estimate utility from clinical questionnaires in schizophrenia: findings from EuroSC.
    Siani C; de Peretti C; Millier A; Boyer L; Toumi M
    Qual Life Res; 2016 Apr; 25(4):925-34. PubMed ID: 26385367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side-effects of antipsychotic medication and health-related quality of life in schizophrenia.
    Bebbington PE; Angermeyer M; Azorin JM; Marwaha S; Marteau F; Toumi M
    Acta Psychiatr Scand Suppl; 2009; (438):22-8. PubMed ID: 19132963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
    J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of antipsychotic side effects on attitudes towards medication in people with schizophrenia and related disorders.
    Chiang YL; Klainin-Yobas P; Ignacio J; Chng CM
    J Clin Nurs; 2011 Aug; 20(15-16):2172-82. PubMed ID: 21539628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes study.
    Novick D; Haro JM; Bertsch J; Haddad PM
    J Clin Psychopharmacol; 2010 Oct; 30(5):531-40. PubMed ID: 20814320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients.
    Karagianis J; Novick D; Pecenak J; Haro JM; Dossenbach M; Treuer T; Montgomery W; Walton R; Lowry AJ
    Int J Clin Pract; 2009 Nov; 63(11):1578-88. PubMed ID: 19780867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of antipsychotic polypharmacy on side-effects and concurrent use of medications in schizophrenic outpatients.
    Hashimoto Y; Uno J; Miwa T; Kurihara M; Tanifuji H; Tensho M
    Psychiatry Clin Neurosci; 2012 Aug; 66(5):405-10. PubMed ID: 22834658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability of atypical antipsychotics in the treatment of adults with schizophrenia or bipolar disorder: a mixed treatment comparison of randomized controlled trials.
    Edwards SJ; Smith CJ
    Clin Ther; 2009 Jun; 31 Pt 1():1345-59. PubMed ID: 19698898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
    Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
    Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitude towards second-generation antipsychotics among patients with schizophrenia and their relatives.
    Karthik MS; Kulhara P; Chakrabarti S
    Hum Psychopharmacol; 2013 Sep; 28(5):457-65. PubMed ID: 23784674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
    Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
    Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in use of psychotropic drugs and drug-induced side effects in schizophrenia patients: findings of the Research on Asia Psychotropic Prescription (REAP) studies.
    Xiang YT; Wang CY; Si TM; Lee EH; He YL; Ungvari GS; Chiu HF; Yang SY; Chong MY; Shinfuku N; Tan CH; Kua EH; Fujii S; Sim K; Yong KH; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N
    Aust N Z J Psychiatry; 2011 Mar; 45(3):193-8. PubMed ID: 21142850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat).
    Lindström E; Lewander T; Malm U; Malt UF; Lublin H; Ahlfors UG
    Nord J Psychiatry; 2001; 55 Suppl 44():5-69. PubMed ID: 11860666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic treatment in older schizophrenia patients with extrapyramidal side effects in Asia (2001 - 2009).
    Xiang YT; Kreyenbuhl J; Dickerson FB; Ungvari GS; Wang CY; Si TM; Lee EH; Chiu HF; Lai KY; He YL; Yang SY; Chong MY; Tan CH; Kua EH; Fujii S; Sim K; Yong MK; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Shinfuku N
    Int J Clin Pharmacol Ther; 2012 Jul; 50(7):500-4. PubMed ID: 22541750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-reported impact of urinary incontinence--results from treatment seeking women in 14 European countries.
    Monz B; Pons ME; Hampel C; Hunskaar S; Quail D; Samsioe G; Sykes D; Wagg A; Papanicolaou S
    Maturitas; 2005 Nov; 52 Suppl 2():S24-34. PubMed ID: 16297579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing side effects from antipsychotic treatment in schizophrenia.
    Kane JM
    J Clin Psychiatry; 2011 Feb; 72(2):e07. PubMed ID: 21382302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.